Clinical Trials Logo

Citation(s)

  •   Abdel-Hameed EA, Ji H, Sherman KE, Shata MT
    Epigenetic modification of FOXP3 in patients with chronic HIV infection. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):19-26. doi: 10.1097/QAI.0b013e3182a1bca4.
  •   Shata MT, Abdel-Hameed EA, Hetta HF, Sherman KE
    Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). J Clin Pathol. 2013 Nov;66(11):967-75. doi: 10.1136/jclinpath-2013

Exploring the Role of Gut-associated TH17 in Microbial Translocation in HIV and HCV/HIV Co-infected Patients

Details for clinical trial NCT01335230